INTRODUCTION {#S2}
============

Methylation of RNA on N^6^-adenosine (m^6^A) is emerging as a critical mechanism regulating different aspects of RNA metabolism and function, including stability ([@R10]; [@R23]; [@R44]), localization ([@R39]), and translation ([@R28]; [@R32]; [@R45]). In mammals, methyltransferases METTL3 (methyltransferase-like 3) and METTL14 form a complex that mediates the addition of methyl groups to adenosines in target RNAs ([@R29]). Readers such as the YTH (YT521-B homology) domain containing proteins bind and interpret m^6^A in a sequence-dependent manner ([@R9]; [@R44]; [@R50]). The presence of m^6^A erasers has also been revealed, suggesting the complex and dynamic regulation of m^6^A ([@R22]; [@R49]). The emerging biological functions regulated by m^6^A include the proliferation and differentiation of embryonic ([@R3]; [@R18]) and neural stem cells ([@R46]; [@R51]), as well as complex behaviors and processes such as circadian rhythms ([@R17]), stress response ([@R15]), and learning ([@R26]).

The RNA-binding protein fragile X mental retardation protein (FMRP) is encoded by the fragile X mental retardation gene (*FMR1*), mutations in which result in fragile X syndrome, the leading genetic cause of intellectual disability. FMRP contains both a nuclear localization sequence (NLS) and a nuclear export sequence (NES), and it is localized in both the nucleus and the cytoplasm ([@R13]; [@R24]). The best-studied function of FMRP is the negative regulation of mRNA translation; thus, fragile X syndrome may result in part from the aberrant expression of FMRP target genes ([@R7]; [@R38]). Functionally, loss of *Fmr1* has been associated with abnormalities in cortical development and dendritic spine formation, which may contribute to aberrant learning and behavior in fragile X syndrome ([@R4]; [@R27]; [@R40]; [@R41]; [@R43]).

Here, we report that FMRP binds m^6^A-modified mRNAs and promotes their nuclear export to regulate neural differentiation. *Fmr1* knockout (*Fmr1*KO) mice show delayed cell cycle progression and neural differentiation, phenocopying methyltransferase *Mettl14* conditional KO (*Mettl14*cKO) mice that are devoid of m^6^A modification ([@R51]). Both *Mettl14*cKO and *Fmr1*KO lead to the nuclear retention of m^6^A-modified FMRP target mRNAs regulating neural differentiation, including components of Notch and Hedgehog signaling pathways. FMRP preferentially binds m^6^A-modified target mRNAs and cooperates with the nuclear export protein CRM1 to facilitate nuclear export. Nuclear retention of methylated FMRP target mRNAs in *Fmr1*KO can be mitigated by wild-type *Fmr1* but not NES-lacking *Fmr1*ΔNES, suggesting that FMRP is sufficient to drive the nuclear export of m^6^A-tagged FMRP target mRNAs, and this mechanism requires the NES-nuclear export. Our findings establish a role for FMRP in regulating m^6^A-dependent mRNA nuclear export during neural differentiation.

RESULTS {#S3}
=======

Genetic KO of *Fmr1* Leads to Delayed Neural Progenitor Cell Cycle Progression {#S4}
------------------------------------------------------------------------------

Target binding site analysis suggests that FMRP may bind to consensus RNA methylation motifs ([@R1]; [@R16]). To test whether the genetic removal of *Fmr1* affects m^6^A-related functions during development *in vivo*, we assessed cortical neural progenitor cell cycle progression, which is regulated by m^6^A ([@R51]). We exposed embryonic day 17.5 (E17.5) wild-type (WT) and *Fmr1*KO mouse embryos to 5-ethynyl-2′-deoxyuridine (EdU) for 24 h and then measured the cell cycle exit by assessing the colocalization of EdU with Ki-67, a marker of proliferation ([Figure 1A](#F1){ref-type="fig"}). The number of cells that had exited the cell cycle within the 24 h of EdU exposure (Ki-67^−^EdU^+^) was significantly decreased in *Fmr1*KO mice compared to WT mice ([Figure 1B](#F1){ref-type="fig"}), suggesting delayed neural progenitor cell cycle exit in *Fmr1*KO mice.

To explore progenitor cell cycle dynamics further, we exposed E17.5 mouse embryos to EdU for 2 h, followed by labeling with the radial glial cell (RGC) marker Pax6 and the mitotic marker phospho-histone H3 (pH3) ([Figure 1C](#F1){ref-type="fig"}). Triple-labeled cells (pH3^+^Pax6^+^EdU^+^) are RGCs that have progressed from S phase to M phase within the 2-h span of EdU exposure. Comparison of this population to the total Pax6^+^EdU^+^ population allows for the assessment of relative rates of cell cycle progression in RGCs. There was a significant reduction in the number of EdU^+^ RGCs that had entered M phase (EdU^+^PH3^+^Pax6^+^) in the *Fmr1*KO mouse cortex ([Figure 1D](#F1){ref-type="fig"}), suggesting that cell cycle progression to M phase is delayed by the loss of *Fmr1 in vivo*.

Further analysis of cell cycle dynamics using flow cytometry revealed prolonged G2/M in cultured *Fmr1*KO neural precursor cells (NPCs) ([Figures 1E](#F1){ref-type="fig"} and [1F](#F1){ref-type="fig"}). Following a 30-min EdU pulse and a 5-h incubation, there were significantly fewer divided *Fmr1*KO NPCs (2n DNA content), accompanied by a greater number of undivided NPCs (4n DNA content), compared to WT ([Figure 1G](#F1){ref-type="fig"}). No difference was observed in EdU incorporation ([Figure S1](#SD1){ref-type="supplementary-material"}). These data indicate a delay in mitotic exit in *Fmr1*KO NPCs. Observations from these three experiments in *Fmr1*KO mice phenocopy altered cell cycle dynamics reported in methyltransferase *Mettl14*cKO mice that have no m^6^A ([@R51]), suggesting that FMRP mediates m^6^A function during neural progenitor differentiation.

Genetic Deletion of *Fmr1* in Mice Results in Prolonged Maintenance of Proliferating Neural Progenitors in the Postnatal Mouse Cortex {#S5}
-------------------------------------------------------------------------------------------------------------------------------------

Delayed cell cycle exit may lead to the extended maintenance of neural progenitors. During mouse cortical development, multipotent Pax6^+^ RGCs and fate-restricted Tbr2^+^ intermediate progenitors (INPs) are largely depleted by postnatal stages ([@R12]; [@R51]). To test whether neural progenitors are maintained postnatally in *Fmr1*KO mice, we pulsed animals with EdU at postnatal day 5 (P5) and analyzed 2 days later at P7. A significant number of EdU^+^Pax6^+^ proliferating RGCs and EdU^+^Tbr2^+^ INPs were present in *Fmr1*KO mice, but very few were present in WT littermates ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). In addition, we examined the maintenance of glial fibrillary acidic protein (GFAP)-expressing radial fibers, which are required for interkinetic nuclear migration and neural progenitor division ([@R42]). These radial fibers are normally not maintained postnatally after the completion of cortical neurogenesis. Whereas there were few radial fibers spanning the cortical wall in WT mouse cortex, by P7 many were present in the *Fmr1*KO cortex ([Figure S2A](#SD1){ref-type="supplementary-material"}). These data indicate that *Fmr1*KO mice maintain proliferating neural progenitors into postnatal stages.

To further characterize the impact of *Fmr1* deletion on cortical development, we examined the number of Pax6^+^ RGCs and Tbr2^+^ INPs in WT and *Fmr1KO* mouse cortices at E17.5, P0, and P6. While differences in the numbers of RGCs and INPs were undetectable at E17.5, both populations showed significant increases in the *Fmr1KO* mouse cortex at P0 and P6 ([Figures 2C](#F2){ref-type="fig"}-[2E](#F2){ref-type="fig"}). No differences in the gross morphology of the cortex at embryonic or postnatal stages were detected ([Figure S2B](#SD1){ref-type="supplementary-material"}). These findings are very similar to the extended maintenance of the proliferating neural progenitors reported in *Mettl14*cKO mice, which are devoid of m^6^A ([@R51]). The neural differentiation abnormalities we identified in *Frm1*KO mice phenocopy the m^6^A-dependent defects found in *Mettl14*cKO mice, suggesting a functional relation between FMRP and m^6^A *in vivo*.

FMRP Preferentially Binds m^6^A-Modified RNAs to Promote Their Nuclear Export during Neural Differentiation {#S6}
-----------------------------------------------------------------------------------------------------------

As previous analyses have suggested that FMRP may bind to consensus RNA methylation motifs ([@R1]; [@R14]; [@R16]), we considered that FMRP could serve as an m^6^A reader to bind and interpret m^6^A to regulate RNA function. To test this possibility, we performed electrophoretic mobility shift assay (EMSA) and bio-layer interferometry analysis to assess the binding affinity of purified FMRP to RNA oligos containing an endogenous m^6^A-modified sequence from mouse *Dll1* mRNA or a consensus m^6^A motif. In both analyses, FMRP binding to RNA probes was significantly enhanced by m^6^A methylation, suggesting that FMRP preferentially binds to methylated RNAs compared to non-methylated RNAs ([Figures 3A](#F3){ref-type="fig"}, [3B](#F3){ref-type="fig"}, [S3A](#SD1){ref-type="supplementary-material"}, and [S3B](#SD1){ref-type="supplementary-material"}).

As an RNA-binding protein, FMRP localizes to both the nucleus and the cytoplasm ([@R13]; [@R24]). Therefore, we hypothesized that FMRP could mediate nuclear RNA export. To test this, we performed RNA sequencing (RNA-seq) to compare mRNA levels in WT and *Fmr1*KO NPC nuclear fractions ([Figures S4A](#SD1){ref-type="supplementary-material"} and [S4B](#SD1){ref-type="supplementary-material"}). We found that genes involved in cell differentiation, neural development ([Figure 3C](#F3){ref-type="fig"}), and embryonic development ([Figure S3C](#SD1){ref-type="supplementary-material"}) were enriched in *Fmr1*KO nuclear fractions, suggesting nuclear retention of these mRNAs upon the loss of *Fmr1*.

To understand how the binding of FMRP to m^6^A affects neural differentiation, we identified all of the mRNAs that are both m^6^A tagged and differentially expressed in *Fmr1*KO NPC nucleus by comparing the above RNA-seq with m^6^A-seq of mouse embryonic neural progenitors ([Figure 3D](#F3){ref-type="fig"}). Gene Ontology analysis revealed enrichment in processes such as neurogenesis, neural differentiation, and regulation of gene expression ([Figure 3E](#F3){ref-type="fig"}), as well as chromatin and DNA binding ([Figure S3D](#SD1){ref-type="supplementary-material"}). Furthermore, pathway analysis yielded terms related to pluripotency and developmental signaling pathways ([Figure 3F](#F3){ref-type="fig"}). Among the mRNAs that are both m^6^A tagged and differentially expressed in *Fmr1*KO NPC nucleus, components of the Notch and Hedgehog pathways ([Figures 3G](#F3){ref-type="fig"} and [3H](#F3){ref-type="fig"}) are particularly interesting, as they are involved in regulating the balance between neural stem cell maintenance and differentiation and have been genetically associated with intellectual disability ([@R5]; [@R33]). We focused on six of the m^6^A-modified, differentially expressed Notch- and Hedgehog-related mRNAs (*Ptch1*, *Dll1*, *Dlg5*, *Fat4*, *Gpr161*, and *Spop*), all of which are also validated FMRP targets ([@R1]). We quantified the levels of these six targets in WT and *Fmr1*KO NPCs by qRT-PCR. Each mRNA showed increased nuclear retention in *Fmr1*KO NPCs ([Figure 3I](#F3){ref-type="fig"}), suggesting a critical role for FMRP in the nuclear export of these methylated target mRNAs. None of these mRNAs showed increased whole-cell levels, indicating that the increase in nuclear levels was not caused by increased general transcription ([Figure S3E](#SD1){ref-type="supplementary-material"}). We next tested the effect of the loss of m^6^A on the nuclear levels of these mRNAs in *Mettl14*cKO NPCs. The elevated nuclear retention of the FMRP target mRNAs observed in *Fmr1*KO NPCs was largely phenocopied in *Mettl14*cKO NPCs ([Figure 3J](#F3){ref-type="fig"}), suggesting a nuclear export mechanism that requires both FMRP and m^6^A.

FMRP Mediates the Nuclear Export of m^6^A-Tagged Target mRNAs through CRM1 {#S7}
--------------------------------------------------------------------------

Our results indicate that FMRP can read m^6^A and that loss of either *Fmr1* or m^6^A results in the reduced nuclear export of methylated FMRP target mRNAs. Nuclear export of mRNA has been shown to be a critical mechanism regulating gene expression ([@R36]; [@R48]). Therefore, nuclear export defects in *Mettl14cKO* NPCs may indicate the altered protein expression of methylated FMRP targets. Western blot analysis revealed a significant reduction in PTCH1 and DLL1 protein levels in *Mettl14cKO* NPCs compared to WT ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). This finding further supports the functional importance of FMRP-m^6^A-mediated nuclear export of mRNA in neural differentiation.

mRNAs can be exported from the nucleus through either NXF1 or CRM1 ([@R20]). CRM1-dependent export is selective, requiring that target mRNAs first bind a CRM1-interacting RNA-binding protein. We identified specific CRM1-FMRP interaction by co-immunoprecipitation ([Figure 4C](#F4){ref-type="fig"}). We also found nuclear accumulation of FMRP following CRM1 inhibition by leptomycin B (LMB) ([Figures 4D](#F4){ref-type="fig"}, [4E](#F4){ref-type="fig"}, and [S4A](#SD1){ref-type="supplementary-material"}), suggesting that FMRP is exported from the nucleus through a CRM1-mediated mechanism. To determine whether m^6^A-tagged FMRP target mRNAs related to Notch and Hedgehog signaling are exported through CRM1, we tested the nuclear levels of these mRNAs in LMB-treated NPCs. Following CRM1 inhibition, there was an increase in the nuclear levels of a majority of these targets ([Figure 4F](#F4){ref-type="fig"}), suggesting that nuclear export of m^6^A-tagged FMRP target mRNAs is mediated through CRM1. To determine the role of m^6^A in this process, we performed RNA immunoprecipitation (RIP) of CRM1 in WT and *Mettl14*cKO NPCs, followed by quantification using qRT-PCR. There was a significant reduction in CRM1 binding to FMRP target mRNAs in *Mettl14*cKO RIP samples ([Figures 4G](#F4){ref-type="fig"} and [4H](#F4){ref-type="fig"}), suggesting that RNA methylation is required for CRM1 binding to m^6^A-modified FMRP target mRNAs and their nuclear export. To further establish the functional link between FMRP and the nuclear export of m^6^A-tagged target mRNAs, we reintroduced either WT *Fmr1* or the NES-lacking *Fmr1*ΔNES ([Figure 4I](#F4){ref-type="fig"}) into *Fmr1*KO NPCs and assessed the levels of methylated FMRP target mRNAs by qRT-PCR. While the expression of WT FMRP significantly mitigated the nuclear retention of the methylated FMRP target mRNAs, expression of the nuclear-restricted FMRPΔNES produced no rescue effect ([Figure 4J](#F4){ref-type="fig"}). These data demonstrate a critical role for FMRP in mediating the nuclear export of m^6^A-tagged target mRNAs to regulate neural differentiation.

DISCUSSION {#S8}
==========

RNA methylation on N^6^-adenosine is emerging as a vital mechanism regulating RNA metabolism and function ([@R9]; [@R31]; [@R34]). Here, we report that FMRP regulates neural differentiation through m^6^A-dependent mRNA nuclear export. We also elucidated the underlying mechanism by which FMRP preferentially binds m^6^A-modified mRNAs and facilitates their nuclear export through CRM1 to regulate neural differentiation.

In *Fmr1*KO mice, we discovered delayed cell cycle progression and extended maintenance of proliferating neural progenitors into postnatal stages, which are also m^6^A-dependent phenotypes found in methyltransferase *Mettl14*cKO mice that have no m^6^A. These findings suggest a functional relation between FMRP and m^6^A in neural differentiation. Our RNA-seq and m^6^A-seq show that both *Mettl14cKO* and *Fmr1KO* lead to nuclear retention of m^6^A-modified FMRP target mRNAs regulating neural differentiation, indicating that both m^6^A methylation and FMRP are required for the nuclear export of target mRNAs. To establish the link between FMRP and m^6^A, we first tested the role of m^6^A in FMRP target mRNA nuclear export by CRM1 RIP in WT and *Mettl14*cKO NPCs. We found significantly reduced CRM1 binding to FMRP target mRNAs in *Mettl14*cKO NPCs that have no m^6^A ([Figures 4G](#F4){ref-type="fig"} and [4H](#F4){ref-type="fig"}). This finding highlights the importance of m^6^A in CRM1-mediated nuclear export of FMRP targets. In addition, we also tested whether the reintroduction of FMRP could rescue the nuclear retention of m^6^A-tagged FMRP target mRNAs, including components of Notch and Hedgehog signaling pathways that have well-established roles in regulating neural proliferation and differentiation. We found that only WT FMRP, not the NES-lacking and nuclear restricted FMRPΔNES, alleviated nuclear retention deficits in *Fmr1*KO NPCs ([Figures 4I](#F4){ref-type="fig"} and [4J](#F4){ref-type="fig"}). Thus, FMRP is sufficient to drive the nuclear export of m^6^A-tagged FMRP target mRNAs, and this mechanism requires the NES-nuclear export. Our findings establish a critical role for FMRP in regulating m^6^A-dependent mRNA nuclear export during neural differentiation.

Recently, in a large-scale screen to establish a global m^6^A interactome using mass spectrometry, FMRP was found to be one of more than 20 candidate proteins that may interact with an m^6^A-modified probe of 4 GGACU repeats with higher affinity in cell lines ([@R14]). However, a separate study found no preferential binding of FMRP to m^6^A-modified RNA probes ([@R52]), although specific enrichment of m^6^A in FMRP targets was discovered. The discrepancy could be due to differences in experimental conditions, design of RNA probes, or the quality of purified FMRP protein used. We used full-length FMRP iso1 purified from Sf9 cells and probe RNA sequences from mouse *Dll1* mRNA containing both consensus FMRP-binding sites and RNA methylation motifs to show that FMRP preferentially binds to methylated RNA in both EMSA and bio-layer interferometry analysis. Our data establish the role of FMRP as an m^6^A reader both *in vivo* and *in vitro*.

The nuclear export of mRNAs related to Notch and Hedgehog signaling was found in our study to require both FMRP and m^6^A. Delta-like (Dll) binding to the Notch receptor drives the expression of *Hes1* to maintain stem cell pluripotency and suppress differentiation ([@R21]). Notch has also been shown to cross-talk with additional pathways, including Hedgehog, to regulate neural stem cell proliferation and differentiation. Hedgehog-induced maintenance of stem cell pluripotency relies in part on the activation of Notch to balance proliferation with differentiation ([@R8]; [@R25]). We found increased nuclear retention of m^6^A-modified FMRP targets related to Notch and Hedgehog pathways in both *Fmr1KO* and *Mettl14cKO* NPCs. Our findings suggest that a disruption in the balance between proliferation and differentiation regulated by FMRP-m^6^A-dependent nuclear export may underlie the aberrant neural differentiation phenotypes observed in *Fmr1KO* and *Mettl14cKO* mice, eventually leading to defects in neuronal function.

We discovered the extended maintenance of neural progenitors into postnatal stages, accompanied by delayed cell cycle progression and neural differentiation in *Fmr1*KO mice. Cell cycle phase and duration are tightly coupled to neurogenic potential ([@R30]; [@R35]). Moreover, there is a strong association between neuronal birth-date and identity ([@R37]). Therefore, the temporal aberrations in neural progenitor cell cycle and differentiation observed in *Fmr1*KO mice may influence cortical development by affecting neuron subtype specification, contributing to functional deficits in fragile X syndrome. Consistent with our observations, alterations of layer-specific neuron migration and localization have been found in *Fmr1*KO mice ([@R27]; [@R43]). In addition, delayed cell cycle exit in *Fmr1*KO progenitors may deregulate the excitatory-inhibitory balance in the developing neural circuitry, as inhibitory interneuron integration into the cortex follows and depends upon pyramidal neuron differentiation and patterning ([@R2]). Defects in these processes in *Fmr1*KO mice could drive the altered synaptic landscape that is characteristic of fragile X syndrome. Our study elucidates a mechanism by which FMRP reads and facilitates the nuclear export of m^6^A-modified mRNAs to regulate neural differentiation, defects in which may contribute to functional deficits in fragile X syndrome.

STAR★METHODS {#S9}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S10}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Yongchao C. Ma (<ma@northwestern.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S11}
--------------------------------------

All animal experiments conducted within this study have been approved by the Institutional Animal Care and Use Committee (Protocol \#IS6359), and performed in accordance with federal regulations governing the use of animals in laboratory research. All animals were maintained in standard housing conditions with 12-hour light/dark cycle and food and water available *ad libitum. Fmr1* mice (*B6.129P2-Fmr1^tm1Cgr/J^* Jackson Laboratory \#003025), originally generated by the [@R11], were obtained through Dr. Anis Contractor from Dr. David Nelson's laboratory, where the original knockout line was backcrossed onto C57/BL6 background. Heterozygous *Fmr1* female mice were bred with C57/BL6 males to yield wild-type and knockout littermates for all FMRP experiments at indicated time points (E17.5, P0, P5, or P7), or utilized for generation of neural precursor cells (NPCs) at E13.5. Because *Fmr1* is an X-linked gene, only males were used for knockout analysis with the mating scheme described.

METHOD DETAILS {#S12}
--------------

### Cell Culture {#S13}

Dorsal forebrains from timed-pregnant E13.5 mouse embryos were digested with Accutase (Fisher) to yield dissociated cortical neural precursor cells (NPCs) for culture. NPCs were carried on plates coated with Matrigel (Corning) at 80 μg/ml and maintained in DMEM-F12 medium (GIBCO) supplemented with B27 (GIBCO), N2 (GIBCO), and Glutamax (GIBCO). A growth factor cocktail containing EGF (PeproTech) (20ng/ml) and basic FGF (PeproTech) (20ng/ml) in Heparin (5 μg/ml) was added to the medium fresh. Cells were carried at densities not exceeding 80%, and all experiments were performed on density- and passage-matched NPC cultures. Cells were incubated in standard conditions: 37°C with 5% CO~2~. Multiple lines of NPCs were generated from independent litters of *Fmr1* wild-type and knockout embryos.

### Immunohistochemistry {#S14}

Brains harvested from embryonic stages were fixed in fresh 4% PFA (Sigma) for six hours at 4°C, then washed extensively in PBS prior to embedding. Postnatal mice were subjected to transcardial perfusion with PBS, then PFA before brains were harvested and fixed in fresh 4% PFA for either six hours (P0), or overnight (P5, P7). Coronal sections (18 μm) were prepared using a Leica CM 3050S cryostat. Slides were baked at 65°C for two hours. For antigen retrieval, slides were submerged in Antigen Unmasking Solution (DAKO) at 95°C for twenty minutes, then rehydrated in PBS for five minutes. Sections were blocked for one hour at room temperature in 0.01% PBS-TritonX containing 3% BSA and 5% goat and donkey serum. Sections were incubated with primary antibodies overnight, and secondary antibodies for one hour at room temperature. All antibodies were diluted in blocking solution as follows: rat anti-Ki-67 (DAKO, 1:10), rabbit anti-GFAP (DAKO, 1:200), rabbit anti-phospho-Histone H3 (CST, 1:400), rabbit anti-Tbr2 (Abcam, 1:400), and mouse anti-Pax6 (BD Biosciences, 1:400). For embryonic EdU experiments, timed-pregnant dames were injected with EdU at a concentration of 150mg/kg for the indicated durations (2 hours or 24 hours). For postnatal EdU experiments, pups were given an injection of EdU at a concentration of 75mg/kg for the indicated duration (forty-eight hours). For EdU detection, the Click-iT Plus EdU Alexa Fluor 647 Imaging Kit (Invitrogen) was used according to manufacturer's protocol. Images were acquired on a Leica DM 2500 epifluorescence microscope outfitted with a RETIGA 4000R camera (Q-Imaging). Cell counts represent the total number of labeled cells (as indicated) within 100 μm bins.

### Flow Cytometry {#S15}

NPCs were exposed to EdU for a duration of thirty minutes, and then either fixed immediately or incubated for five hours and then fixed, and incorporation was detected with the Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Invitrogen) according to manufacturer's protocol. DNA was labeled with 7-AAD (Thermo/Fisher). Data were collected using a BD LSR II Flow cytometer (BD Biosciences). Flow cytometry data were visualized with FlowJo software.

### Nuclear RNA Extraction and Quality Control {#S16}

NPCs were harvested at \~80% confluency with Accutase (Fisher), and nuclear fractions were prepared as described in the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo/Fisher) manufacturer's protocol, with minor modifications. 0.5U/μl of RNase inhibitor (Ambon/Fisher) was added to the CERI reagent to prevent degradation. After separation from the cytoplasmic fraction, the nuclear pellet was washed twice with PBS (prepared in DEPC water), and resuspended in an appropriate volume of TRIzol reagent (Invitrogen). The nuclear pellet was homogenized with a Polytron PT 1200E (Kinematica). RNA was purified using the TRIzol reagent manufacturer's protocol, and quantified using the Quant-iT RNA HS Assay Kit (Invitrogen). The efficiency of separation was determined by measuring nuclear and cytoplasmic RNA fractions by qRT-PCR for the relative quantities of nuclear (*U1*) or cytoplasmic (*beta-actin*) control genes. Only nuclear RNA preparations with high *U1* expression (\~8-fold nuclear increase over cytoplasm) and low *beta-actin* expression (\~7-fold cytoplasmic increase over nucleus) were utilized ([Figure S4](#SD1){ref-type="supplementary-material"}). For qPCR analysis of Leptomycin B (LMB) treated NPCs, a concentration of 20nM was used for 20 hours.

### qRT-PCR {#S17}

RNAs, prepared as described, were reverse-transcribed to produce cDNAs using the QuantaBio qScript cDNA SuperMix (VWR) according to manufacturer's protocol, and the QuantaBio PerfeCTa SYBR® Green SuperMix (VWR) was used for quantitative real-time PCR (qRT-PCR). All reactions were run on the Applied Biosystems 7500 Fast Real-Time PCR System. The Delta-Delta-Ct method was used to compare relative transcript levels between groups. Unaffected control genes used for normalization are noted in the figure legends for each experiment.

### RNA Sequencing and Analysis {#S18}

RNAs were first subjected to Bioanalyzer analysis (Agilent) to assess RNA quality and concentration prior to sequencing. Libraries of nuclear fraction RNAs were prepared according to the TruSeq RNA-Seq Library protocol (Illumina). Sequencing was performed using the Illumina NextSeq500, 75SE High Output (100 million reads). Gene ontology analysis was performed using the TOPPFUN module of TOPPGENE ([@R6]). Pathway analysis was performed using Consensus PathDB ([@R19]). The gene interaction network schematic was generated using GENEmania ([@R47]). Gene sets displayed in heatmaps were obtained from the GO term gene list as indicated within the figures. m^6^A sequencing data used to generate the list of overlapping *Fmr1*/m^6^A-tagged genes was reported previously ([@R51]).

### Immunoprecipitation {#S19}

Cortices were harvested from *Fmr1* wild-type and KO mice and homogenized with a Kinematica Polytron PT 2500E electric homogenizer in IP buffer (20mM Tris HCl (pH8), 137mM NaCl, 1% Triton-X, 2mM EDTA) supplemented with protease inhibitor cocktail (Roche). Equal amounts of wild-type and KO lysates were used for each IP reaction, and an equal amount of wild-type lysate was used for the IgG control IP reaction. Lysates were precleared with Protein A/G PLUS Agarose beads (SCBT) for one hour at 4°C, followed by a three-hour incubation with antibody (2 μg of CRM1 or 2.75 μg of FMRP) at 4°C. Protein A/G PLUS beads were then added for an overnight 4°C incubation. Beads were washed extensively (10mM Tris (pH7.4), 1mM EDTA, 1mM EGTA, 150mM NaCl, 1% Triton-X, 0.2mM NaVO~3~) before elution of bound IP complexes for western blot analysis. IP reactions were repeated at least three times, each time with consistent results. One representative experiment is shown. Inputs shown are 1%.

### RNA Immunoprecipitation (RIP) {#S20}

Starting material for each RIP reaction was \~16 million NPCs. Cells were cross-linked with \~1% EM-grade formaldehyde (Polysciences) for 15 minutes with gentle shaking. Glycine was added to a concentration of \~0.2M and shaken gently for five minutes to stop the reaction. Cells were collected, centrifuged to pellet, and resuspended in iced PBS (prepared in DEPC water). Cells were centrifuged to pellet, and washed twice more with PBS. The pellet was next resuspended in nuclear isolation buffer (0.256M sucrose, 8mM Tris HCl (pH7.5), 4mM MgCl~2~, 1% Triton-X) and incubated on ice for twenty minutes with mixing at regular intervals. Cells were then pelleted by centrifugation, resuspended in 1 mL of RIP buffer (150mM KCl, 25mM Tris HCl (pH7.4), 5mM EDTA, 0.5mM DTT, 0.5% NP40) supplemented with protease inhibitor cocktail (Roche) and RNase inhibitors (Fisher/Ambion). Cells were sheared with twenty strokes of a glass dounce homogenizer (Wheaton), then incubated on a rotator overnight at 4°C with 4 μg of CRM1 antibody (Bethyl). Protein A Dynabeads (Invitrogen) were then added and rotated for 3 hours at 4°C. Dynabeads were pelleted using a magnetic rack and washed four times with RIP buffer, then once with PBS. Beads were resuspended in 200nM RIP buffer containing 40U/ml RNase inhibitor and 20 μg of Proteinase K (VWR), and incubated at 42°C for one hour followed by one hour at 65°C. TRIzol was then added to the beads and RNA was purified as described.

### Electrophoretic Mobility Shift Assay (EMSA) {#S21}

Full-length FMRP isoform 1 protein, tagged with six histidine on the amino-terminus, was purified from codon-optimized baculovirus-infected Sf9 cells by Dr. Yang Xiang at ABclonal. Biotinylated oligos were synthesized containing mouse *Dll1*mRNA sequence, 5′-GAACACCAACAAGAAGGCGGXCUUUCACGGGGXCCAUGGAGCCGA-3′ or a consensus RNA methylation sequence, 5′-CGUGGXCUGGCU-3′ (X = A or m^6^A). In addition, oligos containing a mutated consensus sequence were synthesized 5′-GAUACXGAGAAG-3′. RNA probes were resuspended in DEPC-treated water and denatured by heating to 65°C for ten minutes. Recombinant FMRP protein was diluted in binding buffer (10mM HEPES, pH 8.0; 50mM KCl; 1mM EDTA; 0.05% Triton X-100; 5% glycerol; 10 μg/ml salmon sperm DNA; 1mM DTT; 40U/ml RNasin) to produce graded concentrations. One part RNA probe (20nM final concentration) was then mixed with one part protein (0nM, 125nM, 250nM, 500nM, and 1000nM final concentrations) and incubated at room temperature for thirty minutes. A rabbit anti-FMRP antibody (Cell Signaling Technology) or control rabbit IgG was added to binding reactions to induce supershift. The RNA probe-protein mixtures were run on a 4%--20% TBE gradient gel (Novex) and transferred onto a BioDYNE B nylon membrane (Fisher) using a Trans-Blot Turbo semi-dry transfer system (BioRad). The membrane was crosslinked using a UV Staratlinker 2400 (Stratagene) set to 180mg/cm^2^ for 45 to 60 s. Binding was detected using the Chemiluminescent Nucleic Acid Detection Module (Fisher). Densitometry measurements of all bands were made using the measurement log feature in Adobe Photoshop to calculate the dissociation constant (K~d~). Results are averaged from three independent experiments.

### Bio-Layer Interferometry Analysis {#S22}

Bio-layer interferometry analysis of FMRP binding to the short m^6^A-modified and non-modified RNA oligos was assessed using the BLItz system (Forte Bio). Purified His-tagged FMRP (isoform 1) was loaded onto penta-His biosensors. Binding to m^6^A-modified and non-modified RNA probes was recorded at the following RNA concentrations: 5000nM, 2500nM, 500nM, 150nM, and 0nM. Reagents were prepared in binding buffer containing 100mM KCl, 20mM HEPES, 1mM EDTA, 0.05% Triton-X, 5% glycerol, and 1mM DTT. Each reaction was performed using 30 s for all baselines, 120 s for loading, 120 s for association, and 120 s for dissociation. K~D~ was analyzed using MATLAB's nonlinear curve-fit function as described above, and reported data represent three replicates.

### Western Blot {#S23}

Nuclear and cytoplasmic fractions were prepared for western blot analysis according to the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo/Fisher) protocol and supplemented with protease inhibitor cocktail (Roche). Samples were run on SDS-PAGE, followed by transfer onto PVDF membranes. Membranes were blocked for one hour at room temperature in 5% nonfat milk, incubated with primary antibodies overnight at 4°C, and incubated with secondary antibodies for one hour at room temperature. Primary antibodies were diluted in 0.01% TBS-Tween containing 5% BSA as follows: Rabbit anti-FMRP (Cell Signaling Technology, 1:1000), Rabbit anti-PTCH1 (Proteintech, 1:1000), Rat anti-DLL1 (Millipore-Sigma, 1:500), rabbit anti-CRM1 (Bethyl Labs, 1:2500), mouse anti-Fascin (Santa Cruz Biotechnology, 1:1000), mouse anti-Lamin A/C (Cell Signaling Technology, 1:500), mouse anti-beta-actin (Sigma, 1:2000), and mouse anti-beta tubulin (Fisher, 1:2000). For western blot analysis of Leptomycin B (LMB)-treated NPCs, a concentration of 40nM LMB was used for 20 hours.

### Nucleofection of NPCs {#S24}

*Fmr1*KO NPCs were cultured as described. Dr. Stephanie Ceman kindly provided *pEGFP-Flag-mFmr1 WT* and *pEGFP-Flag-mFmr1ΔNES* plasmids ([@R24]). Nucleofection was performed using the Amaxa P3 Primary Cell 4D-Nucelofector X kit (Lonza) according to manufacturer's protocol. Per reaction, about six million cells and 5 μg of plasmid DNA were used. The program "DS113" was utilized for all reactions. Following nucleofection, NPCs were cultured for 24 hours prior to harvesting nuclear and cytoplasmic fractions as described. All samples used for analysis showed comparable nuclear and cytoplasmic separation based on qRT-PCR analysis, and comparable nucleofection efficiency based on GFP fluorescence.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S25}
---------------------------------------

Statistical analysis was performed using Prism7 software (Graphpad). Non-linear curve fitting, used to determine the dissociation constant in [Figure 3B](#F3){ref-type="fig"}, was performed using MATLAB (MathWorks). Specific details regarding the statistical test used, number of samples (n), and number of experimental replicates are in the figure legends. All graphs present mean + SEM. For all experiments, an alpha of 0.05 was used and significance level is indicated as follows: ns p \> 0.05, \* p ≤ 0.05, \*\* p ≤ 0.01, \*\*\* p ≤ 0.001, \*\*\*\* p ≤ 0.0001. The distributions of all datasets were analyzed prior to analysis to confirm the applicability of the statistical approach (i.e., verify Normal distribution of data subjected to t test).

DATA AND CODE AVAILABILITY {#S26}
--------------------------

Sequencing data have been deposited to the Gene Expression Database (GEO) at NCBI. Accession: GSE121809
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![Genetic Knockout of *Fmr1* Leads to Delayed Neural Progenitor Cell Cycle Progression\
(A) Analysis of cell cycle exit in WT and *Fmr1*KO E17.5 cortical progenitors. EdU (24 h) staining is shown in red and Ki-67 in green. Enlarged sections (bottom) highlight Ki-67^+^EdU^+^ cells (arrows). Scale bars, 25 μm.\
(B) Significantly fewer EdU^+^ cells exit the cell cycle during the 24-h EdU exposure in *Fmr1*KO cortex (\*\*\*\*p ≤ 0.0001; n = 5 WT, 6 KO mice). Data are presented as mean + SEM.\
(C) Analysis of M phase entry in WT and *Fmr1*KO cortical progenitors. pH3 staining is shown in red, Pax6 in green, and EdU in blue. Scale bar, 25 μm.\
(D) Significantly fewer EdU^+^ RGCs entered mitosis within the 2-h EdU exposure in *Fmr1*KO cortex (\*\*p = 0.0017; n = 6 WT, 6 KO mice). Data are presented as mean + SEM.\
(E) FACS analysis of cell cycle dynamics in WT and *Fmr1*KO NPCs. Cells labeled by EdU are shown in the upper quadrants. Cells that divided during the 5-h incubation are shown in green and cells remaining in G2/M are in red.\
(F) Histograms comparing 2n (divided) and 4n (undivided) NPCs between WT and *Fmr1*KO.\
(G) Significantly fewer *Fmr1KO* EdU^+^ NPCs completed division by the end of 5 h compared to EdU^+^ WT NPCs (\*\*p = 0.0018; n = 6 WT, 6 KO mice). Data are presented as mean + SEM.](nihms-1535564-f0002){#F1}

![Genetic Deletion of *Fmr1* in Mice Results in Extended Maintenance of Proliferating Neural Progenitors in the Postnatal Mouse Cortex\
(A) Immunostaining of Pax6 (green) and EdU (red) in P7 cortex from WT and *Fmr1*KO mice exposed to EdU (48 h). The number of Pax6^+^EdU^+^ cells, marked by arrowheads, is increased in KO cortex (\*\*\*p = 0.0008; n = 5 WT, 4 KO mice). Scale bar, 25 μm. Data are presented as mean + SEM.\
(B) Immunostaining of Tbr2 (green) and EdU (red) in P7 cortex from WT and *Fmr1*KO mice exposed to EdU (48 h). The number of Tbr2^+^EdU^+^ cells, marked by arrowheads, is increased in KO cortex (\*\*p = 0.0018; n = 5 WT, 4 KO mice). Scale bar, 25 μm. Data are presented as mean + SEM.\
(C) Immunostaining of Pax6 (green) and Tbr2 (red) in WT and *Frm1*KO cortex at E17.5, P0, and P6. Scale bar, 50 μm.\
(D and E) Pax6^+^ (D) and Tbr2^+^ (E) cells are increased in *Fmr1*KO cortex: E17.5, Pax6^+^ (p = 0.1996; n = 3WT, 4 KO mice) and Tbr2^+^ (p = 0.053; n = 3 WT, 4 KO mice); P0, Pax6^+^ (\*\*p = 0.0029; n = 7 WT, 7 KO mice) and Tbr2^+^ (\*\*\*\*p \< 0.0001; n = 7 WT, 7 KO mice); P6, Pax6^+^ (\*\*p = 0.0058; n = 5WT, 6KO mice) and Tbr2^+^ (\*\*p = 0.0059; n = 5 WT, 6 KO mice). Data are presented as mean + SEM.](nihms-1535564-f0003){#F2}

![FMRP Preferentially Binds m^6^A-Modified RNAs to Promote Their Nuclear Export in Regulating Neural Differentiation\
(A) EMSA comparing FMRP binding to non-methylated (left) or methylated (right) RNA.\
(B) Steady-state analysis of FMRP binding to methylated or non-methylated RNA using bio-layer interferometry. Results are averaged from three independent experiments.\
(C) Heatmaps comparing WT and *Fmr1*KO NPC nuclear expression of genes related to cell differentiation (left) and nervous system development (right).\
(D) Venn diagram showing RNAs that are m^6^A modified and differentially expressed in *Fmr1*KO nucleus.\
(E) Gene Ontology (GO) analysis of RNAs that are both differentially expressed in *Fmr1*KO nucleus and m^6^A modified. Biological processes (top) and disease associations (bottom) are shown.\
(F) Pathway analysis of RNAs that are both differentially expressed in *Fmr1KO* nucleus and m^6^A modified.\
(G) Gene interaction network of Hedgehog- and Notch-related signaling components and their cross-talk. m^6^A-tagged FMRP targets are outlined in yellow.\
(H) Coverage plot of m^6^A modification of *Dll1* mRNA.\
(I) RNAs of Hedgehog- and Notch-related components are retained in *Fmr1*KO nucleus quantified by qRT-PCR: *Dlg5* (\*p = 0.0324), *Dll1* (\*p = 0.0433), *Fat4* (\*\*p = 0.0065), *Gpr161* (\*\*p = 0.0020), *Ptch1* (\*p = 0.0262), and *Spop* (\*\*\*p = 0.0006); n = 5 WT, 3 KO biological replicates. Normalization is to *U1*. Data are presented as mean + SEM.\
(J) RNAs of Hedgehog- and Notch-related components are retained in *Mettl14*cKO nucleus quantified by qRT-PCR: *Dlg5* (\*p = 0.0180), *Dll1* (\*\*p = 0.0016), *Fat4* (\*\*p = 0.0021), *Gpr161* (\*p = 0.0361), *Ptch1* (\*p = 0.0164), and *Spop* (\*\*\*\*p \< 0.0001); n = 3 WT, 4 cKO biological replicates. Normalization is to *U1*. Data are presented as mean + SEM.](nihms-1535564-f0004){#F3}

![FMRP Mediates the Nuclear Export of m^6^A-Tagged FMRP Target mRNAs through CRM1\
(A) Western blot of PTCH1 and DLL1 in WT and *Mettl14*cKO NPC whole-cell lysates.\
(B) PTCH1 (\*p = 0.0178; n = 3 WT, 3 cKO biological replicates) and DLL1 (\*\*p = 0.0045; n = 3 WT, 3 cKO biological replicates) protein levels are significantly decreased in *Mettl14*cKO NPCs. Data are presented as mean + SEM.\
(C) Immunoprecipitation of CRM1 (top) or FMRP (bottom) co-precipitates FMRP or CRM1, respectively, in the WT mouse cortex.\
(D) Western blot of CRM1 inhibition by LMB in WT NPC nuclear fractions. Lamin A-C serves as loading control and fascin as a positive control.\
(E) The nuclear FMRP level is elevated in WT NPCs following LMB treatment (40 nM) (\*\*p = 0.0069; n = 3 biological replicates). Data are presented as mean + SEM.\
(F) Notch- and Hedgehog-related RNAs show nuclear retention in WT NPCs following LMB treatment (20 nM) quantified by qRT-PCR: *Dlg5* (\*p = 0.0170), *Dll1* (\*\*\*p = 0.0006), *Fat4* (p = 0.5815), *Gpr161* (\*p = 0.0154), *Ptch1* (\*\*p = 0.0048), and *Spop* (p = 0.0518); n = 4 vehicle, 6 LMB biological replicates. Normalization is to *Snora3*. Data are presented as mean + SEM.\
(G) CRM1 RIP from WT or *Mettl14*cKO NPCs.\
(H) CRM1 binding to Notch- and Hedgehog-related RNAs is reduced in *Mettl14*cKO NPCs quantified by qRT-PCR: *Dll1* (\*\*p = 0.01), Gpr161 (\*\*\*p = 0.00029), *Ptch1* (\*\*\*p = 0.0002), and *Spop* (\*\*\*\*p \< 0.0001); n = 3 biological replicates. Normalization is to *U1*. Data are presented as mean + SEM.\
(I) Cytoplasmic localization of FMRP-WT and nuclear localization of FMRPΔNES in *Fmr1*KO NPCs. Scale bar, 20 μm.\
(J) Nuclear retention of target mRNAs in *Fmr1*KO NPCs is rescued by the expression of WT (*Dll1* \[\*\*\*\*p \< 0.0001\], Gpr161 \[\*p = 0.026\], *Ptch1* \[\*\*p = 0.008\], and *Spop* \[\*\*p = 0.006\]; n = 3 biological replicates) but not ΔNES *Fmr1* (*Dll1* \[p = 0.372\], *Gpr161* \[p = 0.253\], *Ptch1* \[p = 0.672\], *Spop* \[p = 0.78\]; n = 3 biological replicates). Data are presented as mean + SEM.](nihms-1535564-f0005){#F4}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                 SOURCE                                IDENTIFIER
  --------------------------------------------------------------------------------------------------- ------------------------------------- ----------------------------------------------------------------------------
  Antibodies                                                                                                                                
  Mouse monoclonal anti-Pax6 (clone 018-1330)                                                         BD Biosciences                        Cat\# 561462; RRID:AB_10715442
  Rabbit polyclonal anti-Tbr2                                                                         Abcam                                 Cat\# ab23345; RRID:AB_778267
  Rabbit polyclonal anti-GFAP                                                                         DAKO                                  Cat\# Z0334; RRID:AB_10013382
  Rat monoclonal anti-Ki-67                                                                           DAKO                                  Cat\# M7249; RRID:AB_2250503
  Rabbit polyclonal anti-phospho Histone H3                                                           CST                                   Cat\# 9701; RRID:AB_331535
  Rabbit polyclonal anti-FMRP                                                                         CST                                   Cat\# 4317S; RRID:AB_1903978
  Rabbit polyclonal anti-CRM1                                                                         Bethyl Labs                           Cat\# A300-469A; RRID:AB_451004
  Rabbit polyclonal anti-Lamin A/C                                                                    CST                                   Cat\# 2032; RRID:AB_2136278
  Mouse monoclonal anti-Beta-tubulin                                                                  Fisher                                Cat\# A2228; RRID:AB_476697
  Mouse monoclonal anti-Fascin                                                                        SCBT                                  Cat\# sc-21743; RRID:AB_627580
  Rabbit polyclonal anti-PTCH1                                                                        Proetintech                           Cat\# 17520-1-AP; RRID:AB_2176561
  Rat monoclonal anti-DLL1                                                                            Millipore/Sigma                       Cat\# MABN2284
  Peroxidase AffiniPure Goat Anti-Rabbit IgG (H+L)                                                    Jackson Immunoresearch                Cat\# 111035003
  Peroxidase AffiniPure Goat Anti-Mouse IgG (H+L)                                                     Jackson Immunoresearch                Cat\# 115035003
  Cy3 AffiniPure Donkey Anti-Rabbit IgG (H+L)                                                         Jackson Immunoresearch                Cat\# 711165152
  Cy2 AffiniPure Donkey Anti-Mouse IgG (H+L)                                                          Jackson Immunoresearch                Cat\# 715225150
  Cy2 AffiniPure Donkey Anti-Rat IgG (H+L)                                                            Jackson Immunoresearch                Cat\# 712225153
  Chemicals, Peptides, and Recombinant Proteins                                                                                             
  FMRP Recombinant Protein (isoform 1)                                                                AB Clonal                             N/A
  EdU (5-ethynyl-2-deoxyuridine)                                                                      Invitrogen                            Cat\# A10044
  Paraformaldehyde                                                                                    Sigma                                 Cat\# P6148-1kg CAS 30525-89-4
  PFA, 16% ultrapure EM grade                                                                         Polysciences                          Cat\# 18814-20
  Target Retrieval Solution                                                                           Agilent/DAKO                          Cat\# S1699
  7-AAD                                                                                               Thermo Fisher Scientific              Cat\# A1310
  StemPro Accutase                                                                                    Fisher Scientific                     Cat\# A1110501
  SUPER Rase In RNase inhibitor                                                                       Fisher Scientific/Ambion              Cat\# AM2696
  Matrigel                                                                                            Corning                               Cat\# \#354234
  DMEM-F12                                                                                            Fisher Scientific/GIBCO               Cat\# 11320-033
  N-2 Supplement                                                                                      Fisher Scientific/GIBCO               Cat\# 17502048
  B27 serum free supplement                                                                           Fisher Scientific/GIBCO               Cat\# 17504-044
  Glutamax                                                                                            Fisher Scientific/GIBCO               Cat\# 35050061
  Recombinant Human bFGF                                                                              PeproTech                             Cat\# 100-18B
  recombinant murine EGF                                                                              PeproTech                             Cat\# 315-09
  Heparin                                                                                             J.T. Baker/Avantor                    Cat \# M916-00
  Complete, Mini, EDTA-free Protease Inhibitor Cocktail                                               Roche                                 Cat\# 11836170001
  Proteinase K                                                                                        VWR                                   Cat\# 97062-670
  Normal Goat Serum                                                                                   Jackson Immunoresearch                Cat\# 005000121
  Normal Donkey Serum                                                                                 Jackson Immunoresearch                Cat\# 017000121
  Bovine Serum Albumin, Fraction V, Heat Shock Treated                                                Fisher Scientific                     Cat\# BP1600100
  Leptomycin B                                                                                        SCBT                                  Cat\# sc-358688, CAS 87081-35-4
  TRIzol                                                                                              Invitrogen                            Cat\# 15-596-026
  Critical Commercial Assays                                                                                                                
  Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit                                          Invitrogen                            Cat\# C10635
  Click-iT Plus EdU Alexa Fluor 647 Imaging Kit                                                       Invitrogen                            Cat\# C10640
  Chemiluminescent Nucleic Acid Detection Module                                                      Fisher Scientific/Pierce              Cat\# PI89880
  NE-PER Nuclear and Cytoplasmic Extraction Kit                                                       Thermo Fisher Scientific              Cat\# PI78835
  QuantaBio PerfeCTa SYBR® Green SuperMix with Low ROX                                                VWR                                   Cat\# 101414-162
  QuantaBio qScript cDNA SuperMix                                                                     VWR                                   Cat\# 101414-106
  Quant-iT RNA HS Assay Kit                                                                           Invitrogen                            Cat\# Q32852
  TruSeq RNASeq Library Prep Kit                                                                      Illumina                              Cat\# RS-122-2001
  Deposited Data                                                                                                                            
  *Fmr1* Nuclear Fraction RNA Seq data                                                                This paper                            GSE121809
  Experimental Models: Cell Lines                                                                                                           
  *Nestin-Cre*^+/+^*; Mettl14^f/f^* --derived NPCs                                                    [@R51]                                N/A
  Experimental Models: Organisms/Strains                                                                                                    
  B6.129P2-*Fmr1^tm1Cgr^*/J                                                                           Jackson Laboratory                    RRID:IMSR_JAX:003025
  Oligonucleotides                                                                                                                          
  m^6^A *Dll1* oligo: 5′-GAACACCAACAAGAAGGCGGXCUUUCACGGGG [m]{.ul}^[6]{.ul}^[A]{.ul}CCAUGGAGCCGA-3′   This paper                            N/A
  Non-m^6^A *Dll1* oligo: 5′-GAACACCAACAAGAAGGCGGXCUUUCACGGGG[A]{.ul}CCAUGGAGCCGA-3′                  This paper                            N/A
  m^6^A short oligo: 5′-CGUGG [m]{.ul}^[6]{.ul}^[A]{.ul}CUGGCU-3′                                     This paper                            N/A
  Non-m^6^A short oligo: 5′-CGUGG[A]{.ul}CUGGCU-3′                                                    This paper                            N/A
  m^6^A mutated oligo: 5′-GAUAC [m]{.ul}^[6]{.ul}^[A]{.ul}GAGAAG-3′                                   This paper                            N/A
  Non-m^6^A mutated oligo: 5′-GAUAC[A]{.ul}GAGAAG-3′                                                  This paper                            N/A
  Primers for qPCR, see [Table S1](#SD1){ref-type="supplementary-material"}                           This paper                            N/A
  Software and Algorithms                                                                                                                   
  FlowJo                                                                                              FlowJo, LLC                           RRID:SCR_008520, <https://www.flowjo.com>
  TOPPGENE                                                                                            [@R6]                                 RRID:SCR_005726, [https://toppgene.cchmc.org](https://toppgene.cchmc.org/)
  GeneMANIA                                                                                           [@R47]                                RRID:SCR_005709, <http://genemania.org>
  Consensus Path-DB                                                                                   [@R19]                                <http://cpdb.molgen.mpg.de>
  R                                                                                                   R Project for Statistical Computing   RRID:SCR_001905, <https://www.r-project.org>
  MATLAB                                                                                              MathWorks                             RRID:SCR_001622, <https://www.mathworks.com/products/matlab.html>
  Prism7                                                                                              GraphPad                              SCR_002798; <https://www.graphpad.com>
  Other                                                                                                                                     
  Protein A Dynabeads                                                                                 Invitrogen                            Cat\# 10-001-D
  Protein A/G PLUS-Agarose                                                                            SCBT                                  Cat\# sc-2003; RRID:AB_10201400
  Kinematica Polytron PT 1200E Electric Homogenizer                                                   Fisher Scientific                     Cat\# 05-400-261
  5 Prime Phase Lock Gel Heavy 2 ml                                                                   VWR                                   Cat \#10847-802
  BioDYNE B nylon membrane                                                                            Fisher Scientific/Pierce              Cat \#77016
  Dip and Read Anti-Penta-HIS (HIS1K) Biosensors                                                      Forte Bio                             Cat \#18-5120

###### Highlights

-   FMRP reads m^6^A to promote mRNA nuclear export in neural differentiation

-   Neural progenitor differentiation is delayed by knockout (KO) of *Fmr1* or *Mettl14*

-   Both *Mettl14*KO and *Fmr1*KO lead to nuclear retention of m^6^A-tagged FMRP target mRNAs

-   FMRP preferentially binds m^6^A-tagged mRNAs to facilitate nuclear export through CRM1
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